Low Tidal Volume Strategy In Cardiogenic Pulmonary Edema: The Logical Trial (LOGICAL)
Some people with heart failure develop fluid buildup in the lungs and need a breathing machine while they are treated in an intensive care unit. The amount of air delivered with each breath may affect how quickly they recover.
The LOGICAL study will compare two ways of setting the breathing machine: delivering a lower or an intermediate amount of air with each breath. About 300 adults in intensive care units across Spain will be randomly assigned to one of these strategies.
The study aims to find out whether the lower amount of air increases the number of days patients are alive and breathing without the machine during the first 28 days after assignment. The researchers will also assess other outcomes, including survival and length of stay in the intensive care unit and hospital.
研究概览
地位
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Dr Laura Amado-Rodríguez
- 电话号码:+34 985108000
- 邮箱:laura.amado@sespa.es
研究联系人备份
- 姓名:Dr Miguel Ángel Rodríguez Yago
- 电话号码:+34 985108000
- 邮箱:miguelangel.rodriguezyago@gmail.com
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
-
Admission to a participating intensive care unit (ICU).
-
Within the first 24 hours of invasive mechanical ventilation, whether ventilation was started before or after admission to the participating ICU.
-
Expected duration of invasive mechanical ventilation greater than 24 hours.
-
Acute hypoxemic respiratory failure of cardiogenic origin, meeting all three of the following criteria:
-
PaO2/FiO2 ratio below 300 mmHg.
-
Pulmonary congestion shown by at least one of the following:
- Lung ultrasound showing multiple B-lines (at least 3 per zone), distributed bilaterally in at least 2 zones per hemithorax; or
- Chest radiograph showing interstitial or alveolar edema, vascular redistribution, or Kerley B-lines.
-
Evidence of a cardiogenic origin shown by at least one of the following:
- Echocardiographic evidence of elevated left-sided filling pressures (E/e' >14 or E/A >2); or
- Pulmonary capillary wedge pressure >15 mmHg measured with a pulmonary artery catheter.
-
Exclusion Criteria:
- Participation in another interventional clinical trial.
- More than 24 hours of invasive mechanical ventilation.
- Extracorporeal support already initiated.
- Expected extubation within the next 24 hours.
- A predominantly noncardiogenic cause of acute respiratory failure, including acute respiratory distress syndrome, active pneumonia or other pulmonary infection, confirmed pulmonary embolism, or acute lung injury of noncardiac origin.
- Pregnancy.
- Risk of or suspected elevated intracranial pressure.
- Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage IV chronic obstructive pulmonary disease.
- Known pre-existing interstitial lung disease.
- Previous pneumonectomy or lobectomy.
- Terminal condition, a decision to limit life-sustaining treatment, or a do-not-resuscitate order.
学习计划
研究是如何设计的?
设计细节
- 主要用途:支持治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:双倍的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Low Tidal Volume Ventilation
Participants will receive volume-controlled invasive mechanical ventilation with an initial tidal volume of no more than 6 ml/kg of predicted body weight. Tidal volume may be reduced to 4 ml/kg according to respiratory mechanics and clinical tolerance. |
Volume-controlled invasive mechanical ventilation with an initial tidal volume of no more than 6 mL/kg of predicted body weight. Tidal volume may be reduced stepwise to 4 mL/kg according to respiratory mechanics and clinical tolerance. |
|
有源比较器:Intermediate Tidal Volume Ventilation
Participants will receive volume-controlled invasive mechanical ventilation with an initial tidal volume of at least 8 mL/kg of predicted body weight. Tidal volume may be adjusted up to 10 mL/kg while maintaining airway pressures within the protocol-defined safety limits. |
Volume-controlled invasive mechanical ventilation with an initial tidal volume of at least 8 mL/kg of predicted body weight. Tidal volume may be adjusted up to 10 mL/kg while maintaining plateau pressure below 30 cmH₂O and driving pressure below 15 cmH₂O. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Days Alive and Free of Invasive Mechanical Ventilation Through Day 28
大体时间:From randomization through day 28
|
Number of days from randomization through day 28 that a participant is alive and free of invasive mechanical ventilation. Participants who die before day 28 are assigned 0 days. Higher values indicate a more favorable outcome. |
From randomization through day 28
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
All-Cause Mortality at Day 28
大体时间:From randomization through day 28
|
Percentage of participants who die from any cause within 28 days after randomization. |
From randomization through day 28
|
|
Duration of Invasive Mechanical Ventilation
大体时间:From randomization until successful liberation, death, or day 90
|
Time from randomization to successful liberation from invasive mechanical ventilation, defined as remaining free of invasive mechanical ventilation for at least 48 hours. Death before liberation will be considered a competing event in the analysis. |
From randomization until successful liberation, death, or day 90
|
合作者和调查者
调查人员
- 首席研究员:Laura Amado-Rodríguez, MD, PhD、Hospital Universitario Central de Asturias
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
The investigators intend to explore sharing anonymized individual participant data after publication of the main results, subject to ethical approval, applicable data protection requirements, and assessment of re-identification risk. The specific data sets, access process, and availability period have not yet been determined.
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.